The PEPI Cox proportional hazards model uses change of pathologic T stage, lymph node status, the Ki67 proliferative index, and the level of ER expression (Allred score) after 4 months of preoperative endocrine therapy to predict RFS and breast cancer specific survival (BCSS)84. Here, ESR1 is linked to breast cancer.